Dianthus Therapeutics CEO Marino Garcia reports disposal of 166,000 common shares worth $17.97 million
DNTH•CEO reports option exercises and share sales
- Dianthus Therapeutics CEO and President Marino Garcia reported option exercises and share sales on Aug. 7, 2026.
- Exercised options for 166,000 shares at USD 8.44, lifting direct common stock holdings to 231,292 shares.
- Sold 166,000 shares at weighted-average prices around USD 107.49 to USD 110.76, cutting direct holdings to 65,292 shares.
- Directly held stock options fell to 160,004 shares following the exercises.
